AT258471B - Verfahren zur Herstellung von Wirkstoffzubereitungen zur percutanen Verabreichung - Google Patents

Verfahren zur Herstellung von Wirkstoffzubereitungen zur percutanen Verabreichung

Info

Publication number
AT258471B
AT258471B AT578162A AT578162A AT258471B AT 258471 B AT258471 B AT 258471B AT 578162 A AT578162 A AT 578162A AT 578162 A AT578162 A AT 578162A AT 258471 B AT258471 B AT 258471B
Authority
AT
Austria
Prior art keywords
production
active ingredient
percutaneous administration
ingredient preparations
preparations
Prior art date
Application number
AT578162A
Other languages
German (de)
English (en)
Inventor
Friedrich Dr Med Meyer
Original Assignee
Friedrich Dr Med Meyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Friedrich Dr Med Meyer filed Critical Friedrich Dr Med Meyer
Application granted granted Critical
Publication of AT258471B publication Critical patent/AT258471B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A61K8/315—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT578162A 1961-07-20 1962-07-17 Verfahren zur Herstellung von Wirkstoffzubereitungen zur percutanen Verabreichung AT258471B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEM49750A DE1227616B (de) 1961-07-20 1961-07-20 Penetrationsvermittler

Publications (1)

Publication Number Publication Date
AT258471B true AT258471B (de) 1967-11-27

Family

ID=7306610

Family Applications (2)

Application Number Title Priority Date Filing Date
AT92864A AT249268B (de) 1961-07-20 1962-07-17 Verfahren zur Herstellung von Wirkstoffzubereitungen zur percutanen Verabreichung
AT578162A AT258471B (de) 1961-07-20 1962-07-17 Verfahren zur Herstellung von Wirkstoffzubereitungen zur percutanen Verabreichung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT92864A AT249268B (de) 1961-07-20 1962-07-17 Verfahren zur Herstellung von Wirkstoffzubereitungen zur percutanen Verabreichung

Country Status (6)

Country Link
AT (2) AT249268B (no)
BR (1) BR6241165D0 (no)
DE (1) DE1227616B (no)
FR (1) FR1329357A (no)
GB (1) GB1001949A (no)
NL (1) NL281225A (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005032A (en) * 1974-09-25 1977-01-25 Xerox Corporation Liquid crystalline composition having mixed cholesteric-nematic properties
FR2308354A1 (fr) * 1975-04-22 1976-11-19 Bus Louise Lotion cosmetologique destinee aux epidermes atteints d'acne
IT1066697B (it) * 1976-11-08 1985-03-12 Manetti & Roberts Italo Brit Attivatore per composizioni cosmetiche e composizioni cosmetiche che lo contengono
FR2399834A2 (fr) * 1977-08-09 1979-03-09 Bus Louise Lotion cosmetologique destinee aux epidermes atteints d'acne
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
FR2520233A1 (fr) * 1982-01-28 1983-07-29 Oreal Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
JPS5948413A (ja) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd クリダナクを含有する消炎鎮痛外用剤
AU2314184A (en) * 1983-01-10 1984-07-12 Robert Young & Company Limited Endoparasiticidal composition containing levamisole
JPS6013720A (ja) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd 生理的活性剤の吸収促進剤
NZ209100A (en) * 1983-08-22 1987-01-23 Ici Australia Ltd Topical compositions for control of endoparasites
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
FR2566661A1 (fr) * 1984-07-02 1986-01-03 Gendler El Methode pour dissoudre la griseofulvine en vue de preparer une solution de cette substance pour applications locales, qui soit chimiquement stable et douee d'activite biologique
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
JP2905210B2 (ja) * 1989-01-23 1999-06-14 フロイント産業株式会社 経皮、経粘膜吸収促進剤および経皮、経粘膜製剤
AU2783092A (en) * 1991-10-26 1993-05-21 East Riding Laboratories Limited Composition for topical application
AU2808492A (en) * 1991-10-26 1993-05-21 East Riding Laboratories Limited Medicament composition for topical application
CA2132865C (en) * 1992-05-13 2003-12-02 Eun S. Lee Transdermal administration of oxybutynin
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5549888A (en) * 1994-01-31 1996-08-27 Procter & Gamble Aqueous topical anti-acne compositions of low pH
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
US6569661B1 (en) 1999-11-12 2003-05-27 Biomarin Pharmaceutical Inc. Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6426208B1 (en) 1999-11-12 2002-07-30 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6866844B2 (en) 2002-11-07 2005-03-15 Biomarin Pharmaceutical Inc. Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
CN1190190C (zh) * 2001-11-23 2005-02-23 王卫 一种抗病毒、抗菌的斑蝥酸酐药物组合物及其制备方法
EP1603542A1 (en) 2003-03-14 2005-12-14 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
DE102004031210A1 (de) * 2004-06-28 2006-02-09 Trommsdorff Gmbh & Co. Kg MLV-Kosmetikum
GB0915315D0 (en) 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE870323C (de) * 1948-10-02 1953-03-12 Johann Schmid Verfahren zur Herstellung eines Einreibemittels
DE801283C (de) * 1948-10-02 1950-12-28 Johann Schmid Verfahren zur Herstellung eines Einreibemittels

Also Published As

Publication number Publication date
DE1227616B (de) 1966-10-27
BR6241165D0 (pt) 1973-06-14
FR1329357A (fr) 1963-06-07
GB1001949A (en) 1965-08-18
NL281225A (no)
AT249268B (de) 1966-09-12

Similar Documents

Publication Publication Date Title
AT249268B (de) Verfahren zur Herstellung von Wirkstoffzubereitungen zur percutanen Verabreichung
CH441340A (de) Verfahren zur Herstellung von 3-Pyrazolidinon-Derivaten
CH429724A (de) Verfahren zur Herstellung von Thiaxanthenderivaten
AT239788B (de) Verfahren zur Herstellung von neuen β-Carbolin-carbonsäureamid-Derivaten
CH427849A (de) Verfahren zur Herstellung von 1-Phenyl-2-amino-äthanolderivaten
CH445021A (de) Verfahren zur Herstellung von therapeutisch aktiven Präparaten mit langandauernder Wirkung für orale Verabreichung
CH407107A (de) Verfahren zur Herstellung von Dihydrofusidinsäure
AT245568B (de) Verfahren zur Herstellung von neuen Imidazolidin-Derivaten
AT230894B (de) Verfahren zur Herstellung von neuen Pyridazinderivaten
CH427815A (de) Verfahren zur Herstellung von therapeutisch wirksamen Chinolizin-Derivaten
CH439326A (de) Verfahren zur Herstellung von Phenyl-propylamin-Derivaten
CH426847A (de) Verfahren zur Herstellung von neuen therapeutisch wirksamen Pyrazolonderivaten
CH442352A (de) Verfahren zur Herstellung von 2-Alkoxy-3,4-dihydroxy-5-hydroxymethyl-tetrahydrofuranderivaten
CH401062A (de) Verfahren zur Herstellung von 8-Hydroxy-penillinsäure
AT225700B (de) Verfahren zur Herstellung von Phenylalkanolaminderivaten
AT250572B (de) Verfahren zur Herstellung von neuen Heptapeptidderivaten
AT241473B (de) Verfahren zur Herstellung von neuen 1-Azathiaxanthenderivaten
CH420144A (de) Verfahren zur Herstellung des therapeutisch wirksamen 16B-Methyl-prednison-21-acetates
CH407975A (de) Verfahren zur Herstellung von o-Phenäthyl-benzoesäure
CH425804A (de) Verfahren zur Herstellung von neuen pharmakologisch wirksamen Pyrazolidonen
CH418343A (de) Verfahren zur Herstellung von 4-Oxo-6-sulfamyl-1,2,3,4-tetrahydrochinazolinon-derivaten
AT227710B (de) Verfahren zur Herstellung von neuen Pyridazinderivaten
AT232512B (de) Verfahren zur Herstellung von Amino-dithiohydrochinonderivaten
CH447177A (de) Verfahren zur Herstellung von 2-Dehydroemetin-Derivaten
CH415659A (de) Verfahren zur Herstellung von 17-Oxoyohimban- oder -alloyohimbanderivaten